Minneapolis, MN, United States of America

Shravya Srigiri

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 6.9

ph-index = 1


Company Filing History:


Years Active: 2022-2025

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Shravya Srigiri: Innovator in Medical Technology

Introduction

Shravya Srigiri is a prominent inventor based in Minneapolis, MN (US), known for her contributions to medical technology. With a total of two patents to her name, she has made significant strides in the field of cardiac and urological health.

Latest Patents

One of her latest patents is a device and method for atrial tachyarrhythmia detection. This innovative medical device is designed to sense cardiac electrical signals and detect atrial tachyarrhythmia based on these signals. It is capable of determining when far field oversensing criteria are met during the detected atrial tachyarrhythmia, and it can also detect the termination of this condition.

Another notable patent involves tools for transurethral deployment and fixation of grafts for managing and treating urethral strictures. This invention provides a device and method that places and holds a graft at an incised urethral stricture site for a duration of 5-21 days, allowing the graft to adhere effectively. The device includes a delivery component, a graft carrier component, and a removal component, all designed to enter and exit the urethra without causing trauma.

Career Highlights

Shravya has worked with esteemed organizations such as Medtronic, Inc. and The Johns Hopkins University. Her experience in these institutions has contributed to her expertise in medical device innovation.

Collaborations

Some of her notable coworkers include Saul E. Greenhut and Mark L. Brown, who have collaborated with her on various projects.

Conclusion

Shravya Srigiri's work in medical technology showcases her dedication to improving patient care through innovative solutions. Her patents reflect her commitment to advancing healthcare and addressing critical medical challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…